Skip to content

Advertisement

  • Poster presentation
  • Open Access

Influence of cholinergic system modulators on morphine state-dependent memory of passive avoidance in mice

  • 1,
  • 2 and
  • 3
Annals of General Psychiatry20065 (Suppl 1) :S163

https://doi.org/10.1186/1744-859X-5-S1-S163

  • Published:

Keywords

  • Morphine
  • Locomotor Activity
  • Atropine
  • System Modulator
  • Passive Avoidance

Background

In the step-down passive avoidance task and 24 hours after the pre-training administration of morphine, the memory is impaired. The administration of the same dose of morphine as pre-test treatment restored the memory. Since cholinergic system has been reported to be involved in several actions of morphine (e.g.: modulation of memory and analgesia).

Materials and methods

We have investigated the part played by the cholinergic modulator drugs, on the memory recall in mice. The locomotor activity of the animals was studied as well.

Results

The administration of atropine alone (as a peripheral/central muscarinc antagonist) showed no intrinsic activity. When the drug was co-administered with morphine, it prevented significantly the morphine-induced memory recall. Hexamethonium (as a peripheral nicotinic antagonist), showed neither intrinsic activity nor a significant change in the morphine-induced memory recall. Mecamylamine (as a peripheral/central nicotinic antagonist) did not show a significant effect when it was used alone, but when co-administered with morphine it prevented significantly the morphine-induced memory recall. The results with neostigmine (as a peripheral anticholinestrase) were similar to that of hexamethonium. Physostigmine (as a peripheral/central anticholinestrase), induced memory recall by itself. The memory recall of the step-down passive avoidance task was not related to the locomotor activity of the animals.

Discussion

It has been concluded that morphine-induced memory recall might be influenced by the central cholinergic activity.

Authors’ Affiliations

(1)
Department of Physiology and Pharmacology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
(2)
Department of Pharmacology, School of Medicine, Tehran, Iran
(3)
University of Medical Sciences, Tehran, Iran

References

  1. Introini IB, Baratti CM: The impairment of retention induced by beta-endorphin in mice may be a reduction of central cholinergic activity. Behav Neural Biol. 1984, 41: 152-163. 10.1016/S0163-1047(84)90527-2.View ArticlePubMedGoogle Scholar
  2. Bruins Slot LA, Colpaert FC: Opiate state of memory: receptor mechanisms. J Neurosci. 1999, 19: 10520-10529.PubMedGoogle Scholar
  3. Hiramatsu M, Kameyama T: Effects of dynorphine A-(1–13) on carbon monoxide-induced delayed amnesia in mice studied in step-down type passive avoidance task. Eur J Pharmacol. 1995, 282: 185-191. 10.1016/0014-2999(95)00330-N.View ArticlePubMedGoogle Scholar
  4. Baratti CM, Introini IB, Huygens P: Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidation in mice. Behav Neural Biol. 1984, 40: 155-169. 10.1016/S0163-1047(84)90255-3.View ArticlePubMedGoogle Scholar

Copyright

Advertisement